Investigation of Antibody and Immune Responses to SARS-CoV-2 Proteins in COVID-19 Patients
Clinical trial NCT04465981 · UNKNOWN
Trial details
- NCT number
- NCT04465981
- Sponsor
- INanoBio Inc.
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-07-03
- Primary completion
- 2022-06-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.